Pharmaceutical Technology· Robert Barrie·· 2026-10-16AI 评分0
RevMed 胰腺癌药物获欧盟专家小组支持,距欧盟获批更近一步
RevMed’s pancreatic cancer drug inches closer to EU approval after panel’s backing
AI 导读
RevMed 的胰腺癌药物在获得欧盟专家小组支持后,距离欧盟获批更近一步。
来源:Pharmaceutical Technology · pharmaceutical-technology.com